Big Pharma Split Corp. (PRM.TO) Research

Big Pharma Split Corp, a closed-end equity investment fund, was established on September 15, 2017, and maintains its domicile in Canada. Overseen by Harvest Portfolios Group Inc., the fund concentrates its investments primarily within the pharmaceutical sector, targeting publicly traded companies across the United States.

Market snapshot

Symbol
PRM.TO
Price
$13.79
Day change
+2.00%
Market cap
$18.0M
P/E ratio
3.82x
52-week range
10.71-15.5
Sector
Financial Services
Industry
Asset Management

Peer companies

  • Big Banc Split Corp. (BNK.TO)
  • Elysee Development Corp. (ELC.V)
  • Faircourt Gold Income Corp. (FGX.NE)
  • GOAT Industries Ltd. (GOAT.CN)
  • Nations Royalty Corp. (NRC.V)
  • Planet Ventures Inc. (PXI.CN)
  • RE Royalties Ltd. (RE.V)
  • SATO Technologies Corp. (SATO.V)

Open Big Pharma Split Corp. (PRM.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.